Skip to main content
No exploitation reported

CVE-2016-8355

No exploitation reported by the sources we read.

  • Published2017-02-13
  • WeaknessCWE-306

Am I affected?

With a domain, we read the version its public headers and pages expose. A distribution build can carry the fix under an older number.

Description

An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.

Timeline

dates in UTC
  1. 2017-02-1322:59CVE publishedNVD

Observed activity

isMalicious corpus · updated 2026-10-23 18:48 UTC
Indicators tagged with this CVE, per day0 indicators over 7 days
Block these indicators
  • Firewall list (EDL, text): https://api.ismalicious.com/edl/cve/CVE-2016-8355?format=txt
  • CSV export: https://api.ismalicious.com/edl/cve/CVE-2016-8355?format=csv
  • TAXII collection of exploited CVEs
  • The EDL and CSV take an API key on the Pro plan.

Versions per branch

NVD
Smiths-medical cadd-solis medication safety software
BranchAffectedFixed in
1.0= 1.0no fix published
2.0= 2.0no fix published
3.0= 3.0no fix published
3.1= 3.1no fix published

as publishedRanges as NVD and OSV publish them; a distribution’s build can be fixed under an older number.

Distribution builds and vendor advisories

Packages from OSV.dev and products from the vendors' CSAF advisories.

version not verifiedVersions not verified: read as OSV.dev and the vendors publish them, not checked against each vendor's release list.

Vendor advisories

  • ICSMA-16-306-01 CISA4 known affected

    Smiths Medical CADD-Solis Medication Safety Software Vulnerabilities

    Smiths Medical CADD-Solis Medication Safety Software: 1.0 · Smiths Medical CADD-Solis Medication Safety Software: 2.0 · Smiths Medical CADD-Solis Medication Safety Software: 3.0 · +1 more

Full record on NVD

Fix

  1. Mitigation from the vendor CISA ICSMA-16-306-01 · 4 productsSmiths Medical has released new versions of the CADD-Solis Medication Safety Software, which mitigates the identified vulnerabilities. The new versions of Smiths Medical’s CADD-Solis Medication Safety Software are Version 3.2, which is distributed within the continental US, and Version 4.1, which i…
  2. Mitigation from the vendor CISA ICSMA-16-306-01 · 4 productsSmiths Medical recommends that CADD-Solis Medication Safety Software users install the applicable new version. In addition, Smiths Medical also recommends that users take the following additional security measures: Apply strict password standards across systems to include, requiring the use of upp…
  3. Mitigation from the vendor CISA ICSMA-16-306-01 · 4 productsFor additional information about the identified vulnerabilities or to obtain the new version of the CADD-Solis Medication Safety Software, contact Smiths Medical Technical Support at: Telephone: +1 (800) 258 5361 or +01 614 210 7300, Email: (mailto:info.asd@smiths-medical.com).

Detection

Nuclei template
none so far
ProjectDiscovery
Exploit-DB
no entry
Exploit-DB
Proof-of-concept repositories
none listed
PoC-in-GitHub

Sources

  • NVDCVSS 3.09.9read 2026-10-23
  • NVDCVSS 2.09read 2026-10-23
  • NVDweakness (CWE)CWE-306read 2026-10-23
  • FIRST EPSSEPSS score1.5 %2026-10-22

Technical details

CVSS v3 Vector
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Published
2017-02-13
Last Modified
2026-06-17
NVD status
Modified

Frequently asked questions

What is CVE-2016-8355?

An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.

Is CVE-2016-8355 actively exploited?

Active exploitation of CVE-2016-8355 has not been confirmed. Its EPSS score was 1.5% on 2026-10-22, the estimated probability of exploitation in the next 30 days.

What is the CVSS score for CVE-2016-8355?

CVE-2016-8355 has a CVSS v3 base score of 9.9 (CRITICAL severity), with vector string CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H.

Hear about the next vulnerability in your software

Surveillance reads the versions in your stack — a domain, a lockfile or a list — checks each CVE against the ranges its sources publish, and alerts you when one you run is exploited or enters CISA KEV. A version it cannot read stays « version not verified ».

No credit card required · No monthly cap on website lookups · 250 API requests/month